Patents by Inventor Riccarda Granata

Riccarda Granata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
    Patent number: 8222217
    Abstract: An isolated polypeptide comprising any amino acid fragment of unacylated ghrelin or any analog thereof, wherein the polypeptide has an activity selected from the group consisting of a) decreasing blood glucose levels; b) increasing insulin secretion an/or sensitivity; c) binding to insulin-secreting cells; and d) promoting survival of insulin-secreting cells. As well as the use of the polypeptide in the treatment of a disorder associated with impaired glucose metabolism.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: July 17, 2012
    Assignee: Alize Pharma SAS
    Inventors: Ezio Ghigo, Riccarda Granata, Aart Jan Van Der Lely
  • UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20100168033
    Abstract: An isolated polypeptide comprising any amino acid fragment of unacylated ghrelin or any analog thereof, wherein the polypeptide has an activity selected from the group consisting of a) decreasing blood glucose levels; b) increasing insulin secretion an/or sensitivity; c) binding to insulin-secreting cells; and d) promoting survival of insulin-secreting cells. As well as the use of the polypeptide in the treatment of a disorder associated with impaired glucose metabolism.
    Type: Application
    Filed: May 30, 2008
    Publication date: July 1, 2010
    Applicant: ALIZE PHARMA SAS
    Inventors: Ezio Ghigo, Aart Jan Van Der Lely, Riccarda Granata
  • UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080312133
    Abstract: An isolated polypeptide comprising any amino acid fragment of unacylated ghrelin or any analog thereof, wherein the polypeptide has an activity selected from the group consisting of a) decreasing blood glucose levels; b) increasing insulin secretion an/or sensitivity; c) binding to insulin-secreting cells; and d) promoting survival of insulin-secreting cells. As well as the use of the polypeptide in the treatment of a disorder associated with impaired glucose metabolism.
    Type: Application
    Filed: May 30, 2008
    Publication date: December 18, 2008
    Applicant: ALIZE PHARMA SAS
    Inventors: Ezio Ghigo, Riccarda Granata, Aart Jan Van Der Lely